Navigation Links
Potato blight pathogenicity explained by genome plasticity

t breeders to obtain resistant varieties by introducing R genes, either by classical breeding or by genetic modification, may be a waste of time and resources when the genome dynamics of the pathogen population is not understood," says Govers. "Monitoring field populations of plant pathogens at the genome level will be instrumental for predicting the durability of R genes in crop plants."


'"/>

Source:Cold Spring Harbor Laboratory


Page: 1 2 3

Related biology news :

1. Researchers find gene that may be at root of potato blight
2. Lethal needle blight epidemic may be related to climate change
3. Cats indifference towards sugar explained
4. Pleasing plant shapes explained by new computer model
5. Evolution of irreducible complexity explained
6. Man and mouse share genome structures
7. Whole genome fine map of rice completed
8. Study finds more than one-third of human genome regulated by RNA
9. A bacterial genome reveals new targets to combat infectious disease
10. Scientists decipher genome of fungus that can cause life-threatening infections
11. Highly adaptable genome in gut bacterium key to intestinal health

Post Your Comments:
(Date:12/1/2009)... Antennas aren,t just for listening to the radio a...s to GPS devices. Research from North Carolina Sta...nna design creating shape-shifting antennas that ...ing from public safety to military deployment. , ...als, but there are limitations to how far they can...
(Date:11/30/2009)...hose extra helpings of gravy and dessert at the ho...ine than previously thought. According to a new re...SEB Journal ( http://www.fasebj.org ), a diet tha... genes that ultimately cause our bodies to store t... double-whammy as the already difficult task of co...
(Date:11/30/2009)...This release is available in German . , The...aborative Research Centres as of 1 January 2010. T...nts Committee in Bonn. The new centres will initia...illion. In addition, 20 percent overhead funding f...roject. The centres, research topics range from mo...
Breaking Biology News(10 mins):Shape shifters: Researchers create new breed of antennas 2Happy holidays from the groaning board; Western diets turn on fat genes 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9Physiological response may explain why some severely obese patients overeat 48353 1Physiological response may explain why some severely obese patients overeat 48353 2Hypertension among lower status employees lingers well into retirement 8771 1Hypertension among lower status employees lingers well into retirement 8771 2Hypertension among lower status employees lingers well into retirement 8771 3Alzheimers and Even Mild Dementia Hasten Death 48350 1Alzheimers and Even Mild Dementia Hasten Death 48350 2
...L HILL Researchers at the University of North Car...ified a compound that could be modified to treat o...red how a particular gene mutation contributes to ...ent apply to a type of brain tumor called secondar...a larger group of brain tumors called malignant gl...
...d Hughes Medical Institute researchers have design...causes Huntington,s disease without damaging that ...alth and vitality of neurons. Laboratory studies s...educe production of the damaging Huntingtin protei...er 25 percent of patients might benefit from one o...
...icial heart pacemakers have saved and extended the... shortcomings such as a fixed pulse rate and a l... be possible? , Richard Robinson and colleagues ...s certainly think so, and their work published in ...ings the dream a step closer to reality. , The bo...
Other Biology News:UNC study: Scientists identify chemical compound that may stop deadly brain tumors 2New therapeutic strategy could target toxic protein in most patients with Huntington's disease 2New therapeutic strategy could target toxic protein in most patients with Huntington's disease 3New therapeutic strategy could target toxic protein in most patients with Huntington's disease 4Towards a natural pacemaker 2
(Date:12/2/2009)...ire/ -- S*BIO Pte Ltd today announced data present...t The American Society of Hematology 51st Annual M...ill be presented on the clinical results from the ...its safety, tolerability and pharmacokinetic/pharm...from 100 to 600 mg. These doses were administered ...
(Date:12/2/2009)...FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ...tical company focused on endocrine therapy and onc... Administration (FDA) has granted Fast Track desig...r compound, perifosine (KRX-0401), for the treatme...Biopharmaceuticals, Inc. ("Keryx") ( KERX), is AEt...
(Date:12/2/2009)...re/ -- According to the National Institute of Heal...d with diabetes already have some stage of diabeti...e retina caused by leaky blood vessels, is a major... one of the most feared diabetic complications. I...d diabetes for 10 years or more will experience so...
(Date:12/1/2009)...re/ -- Reportlinker.com announces that a new marke..., Chromium - Global Market Trends ,, ht...al-Market-Trends.html ,, Worldwide demand for ...l, while growth in aerospace and industrial gas tu...mium metal. Environmental constraints and rapid de...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
... Efficacy Will Drive Prescription Rates, According...urces, WALTHAM, Mass., Feb. 13 Decision Resource...y firms focusing on pharmaceutical and,healthcare ...y 2009,Centocor/Janssen-Cilag,s ustekinumab will b...2011. Ustekinumab will achieve gold standard statu...
...e Nanotech, Inc.,(OTC Bulletin Board: AVNA), a lea... announced today that at a special meeting of shar... on February 12, 2008, a proposal was,approved to ...l stock from,100,000,000 shares to 225,000,000 sha...the meeting were voted in favor of the proposal to...
... American Country to Approve Treatment, BASINGSTO... 13, Shire plc (LSE: SHP)(NASDAQ: SHPGY )(TSX: SH... announced that ELAPRASE(R),(idursulfase), a human...unter syndrome, has been approved for commercial s...ection against Sanitary Risk (COFEPRIS).,Mexico is...
Other Biology Technology:Centocor/Janssen-Cilag's Ustekinumab Will Become the Gold Standard for Psoriasis By 2011 2Advance Nanotech Announces Shareholder Proxy Vote Results 2Advance Nanotech Announces Shareholder Proxy Vote Results 3Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome 2Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome 3Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome 4
...basic components and protocol required to develop ...tation of a specific protein in 100 l/well of cell...oating and Detection Antibodies, Recombinant Stand...B Substrate Solution (one-step) and Stop Solution....
...R) Competitor Assay Kits are ideal for studying or...pounds using fluorescence polarization (FP). The h...ransferase to the ligand binding domain of human p...ry, fluorescently tagged progesterone ligand, Fluo...
Organic Acid Analysis Standard, 6 vials from Bio-Rad
...ging Systems group announces the availability of K...eaturing high resolution cooled CCD camera technol...radiographic and chromogenic imaging capability. T...m lens provides spatial resolution of up to 10 mic...
Biology Products: